Navigation Links
WuXi PharmaTech Announces Third-Quarter 2010 Results
Date:11/9/2010

55%EBITDA53,747

21,800

147%

101,117

62,705

61%Adjustments:Share-based compensation

1,960

2,590

(24%)

7,029

7,248

(3%)Transaction expenses

1,977

--

*

4,911

--

*Transaction-related employee bonuses

3,721

--

*

3,721

--

*Termination fee recorded to offset transaction expenses

(5,000)

--

*

(5,000)

--

*Termination fee recorded as other income, net

(25,000)

--

*

(25,000)

--

*Impairment charge from discontinued operations33Mark-to-market losses (gains) on foreign-exchange forward contracts(1,150)513*(735)(1,706)(57%)AdjustedEBITDA30,255

24,903

21%

86,076

68,247

26%Income attributable to holders of ADS (Non-GAAP):Basic22,386

17,559

27%

60,600

49,573

22%Diluted22,386

17,559

27%

60,600

49,573

22%Basic earnings per ADS (Non-GAAP)0.32

0.26

25%

0.87

0.73

19%Diluted earnings per ADS (Non-GAAP)0.30

0.24

26%

0.81

0.68

20%Weighted average ADS outstanding – basic 69,659,76968,334,65769,387,01167,759,562Weighted average ADS outstanding – diluted 74,583,83973,529,12974,586,31673,439,494*  Not meaningfulWUXI PHARMATECH (CAYMAN) INC.REVENUE BREAKDOWN(in thousands of U.S. dollars)Three Months Ended September 30, Nine Months Ended September 30,20102009%20102009%Net revenues:China-based Laboratory Services

57,133

47,976

19%

159,778

134,435

19%U.S.-based Laboratory Services

19,628

16,308

20%

56,562

47,934

18%Subtotal

76,761

64,284

19%

216,340

182,369

19%China-based Manufacturing Services

7,086

5,
'/>"/>

SOURCE WuXi PharmaTech (Cayman) Inc
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16

Related medicine technology :

1. WuXi PharmaTech Awarded GLP Certificate from SFDA for Suzhou Toxicology Facility
2. WuXi PharmaTech Schedules Third-Quarter 2010 Earnings Conference Call
3. Professor Steven V. Ley Speaks at WuXi PharmaTech
4. WuXi PharmaTech Awarded GLP Certificate from OECD for Suzhou Toxicology Facility
5. WuXi PharmaTech Announces Second-Quarter 2010 Results
6. WuXi PharmaTech RESCHEDULES Second-Quarter 2010 Earnings Conference Call
7. WuXi PharmaTech Well Positioned to Continue Growing as Independent Company; Will Receive Breakup Fee of $30 million
8. WuXi PharmaTech Appoints Hao Zhou as Chief Financial Officer
9. WuXi PharmaTech Announces First-Quarter 2010 Results
10. WuXi PharmaTech Schedules First-Quarter 2010 Earnings Release
11. WuXi PharmaTech Enters into Collaboration with J&JPRD, a division of Janssen Pharmaceutica for Preclinical Services and Training
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/21/2014)... , July 21, 2014 /PRNewswire-iReach/ -- Nitrosolution.com, a website ... , will celebrate its first anniversary in August. The ... designed to enhance the body,s ability to produce nitric ... is made up of a variety of phytonutrients and ... been found to increase nitric oxide production ...
(Date:7/21/2014)... YORK , July 21, 2014  EHE International, ... exams with a nationwide physician network, today announced that ... Las Vegas, NV has been named an ... the Las Vegas region now ... help proactively maintain their health. "EHE ...
(Date:7/21/2014)... ALBANY, New York , July 21, 2014 /PRNewswire/ ... market report published by Transparency Market Research "E-Clinical Solution ... and Forecast, 2014 - 2020," the global microfluidic device ... and is expected to grow at a CAGR of ... value of USD 6,515.3 million in 2020. ...
Breaking Medicine Technology:Up and Coming Nitric Oxide Supplements Company Nitrosolution.com Celebrates its One Year Anniversary 2EHE International Certifies Dignity Health Medical Group Nevada, LLC as Its Newest Partner 2E-Clinical Solution Software Market is expected to reach USD 6,515.3 million in 2020: Transparency Market Research 2E-Clinical Solution Software Market is expected to reach USD 6,515.3 million in 2020: Transparency Market Research 3E-Clinical Solution Software Market is expected to reach USD 6,515.3 million in 2020: Transparency Market Research 4E-Clinical Solution Software Market is expected to reach USD 6,515.3 million in 2020: Transparency Market Research 5
... Monogram,Biosciences, Inc. (Nasdaq: MGRM ) announced ... Pfizer Inc,s (NYSE: PFE ) phase III ... CCR5-tropic,HIV-1, increased efficacy was shown as a result ... of the enhanced version of Monogram,s Trofile(TM),Assay., ...
... Oct. 26 Paratek Pharmaceuticals, Inc. today,announced positive ... PTK,0796, a first-in-class aminomethylcycline (AMC). The Phase 2 ... (IV) forms of PTK 0796 to,Zyvox(R) in the ... infections (cSSSIs). Paratek,s trial met its primary safety ...
Cached Medicine Technology:Data Reported at ICAAC Indicates Selzentry(TM) Phase III Treatment-Naive Trial Shows Increased Efficacy When Used With Enhanced Trofile(TM) Assay 2Data Reported at ICAAC Indicates Selzentry(TM) Phase III Treatment-Naive Trial Shows Increased Efficacy When Used With Enhanced Trofile(TM) Assay 3Data Reported at ICAAC Indicates Selzentry(TM) Phase III Treatment-Naive Trial Shows Increased Efficacy When Used With Enhanced Trofile(TM) Assay 4Data Reported at ICAAC Indicates Selzentry(TM) Phase III Treatment-Naive Trial Shows Increased Efficacy When Used With Enhanced Trofile(TM) Assay 5Data Reported at ICAAC Indicates Selzentry(TM) Phase III Treatment-Naive Trial Shows Increased Efficacy When Used With Enhanced Trofile(TM) Assay 6Paratek Reports Positive Phase 2 Clinical Data on its New Antibiotic PTK 0796 in Late Breaker Presentation at the 48th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy 2Paratek Reports Positive Phase 2 Clinical Data on its New Antibiotic PTK 0796 in Late Breaker Presentation at the 48th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy 3Paratek Reports Positive Phase 2 Clinical Data on its New Antibiotic PTK 0796 in Late Breaker Presentation at the 48th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy 4
(Date:7/22/2014)... European Bio stimulants Market report defines and segments the ... of revenue. The bio stimulants market in Europe is ... to $940.6 million by 2018, at a CAGR of ... TOC of the Europe Bio stimulants Market report, to ... http://www.micromarketmonitor.com/market/europe-bio-stimulants-1315565884.html , Agriculture contributes to 10% of ...
(Date:7/22/2014)... 2014 Today, Therapy Changes announces the start ... – 18 to help increase their knowledge and ability to ... will learn how to make healthy and positive decisions while ... excitement and adventure, but also a time of major life ... Therapy Changes . , “Teens can at times feel ...
(Date:7/22/2014)... 22, 2014 Alliance Storage ... data archiving solutions, has announced the availability of ... archiving solution. The unique new solution merges optical ... on compliant data archiving across all industries including ... The introduction of the new archiving tier permits ...
(Date:7/22/2014)... July 22, 2014 Thought Technology's ... set of simple tools, designed to help clinicians do ... or no experience with biofeedback. The tools in the ... and elucidate any abnormal patterns to teach them to ... paced world, we are familiar with stress and its ...
(Date:7/22/2014)... from the University of Murcia have studied the ... impulsiveness, a personality trait that causes difficulties in ... stimulus and leads to unplanned actions without considering ... an indicator for predicting the risk of behavioural ... from the University of Murcia analyses whether the ...
Breaking Medicine News(10 mins):Health News:Europe Bio Stimulants Market is Expected to Reach $940.6 Million in 2018 - New Report by MicroMarket Monitor 2Health News:Europe Bio Stimulants Market is Expected to Reach $940.6 Million in 2018 - New Report by MicroMarket Monitor 3Health News:Europe Bio Stimulants Market is Expected to Reach $940.6 Million in 2018 - New Report by MicroMarket Monitor 4Health News:Europe Bio Stimulants Market is Expected to Reach $940.6 Million in 2018 - New Report by MicroMarket Monitor 5Health News:Therapy Changes Announces Teen Support Group Therapy 2Health News:Data Archiving Leader Alliance Storage Technologies Releases Enterprise Class Cloud-Integrated Storage Solution 2Health News:Data Archiving Leader Alliance Storage Technologies Releases Enterprise Class Cloud-Integrated Storage Solution 3Health News:Data Archiving Leader Alliance Storage Technologies Releases Enterprise Class Cloud-Integrated Storage Solution 4Health News:Thought Technology to Present Software for Stress Control at the 2014 American Psychological Association Convention in DC 2Health News:Thought Technology to Present Software for Stress Control at the 2014 American Psychological Association Convention in DC 3Health News:Children's impulsive behaviour is related to their brain connectivity 2
... device that alerts women whether or not they have taken their ... ,The Remember Device developed by Lai Chiu Tang, a student ... to take her pill with a choice of four alerts - ... vibrate mode, reported online edition of BBC News. ,The ...
... will start a health insurance policy next month which will ... that fall under the Phase 1 category will be obliged ... will make the lowest paid the first to benefit from ... the General Authority for Health Services (GAHS) in Abu Dhabi. ...
... Angeles: Pfizer has indicated that recent clinical trials of inhaled ... is found to be useful in regulating blood sugar levels ... Exubera, is slated to be introduced into the United States ... it for use in adults with Type 1 or Type ...
... Mittal it was appropriate for Rahul Mahajan to be taken ... taken to Apollo hospital and not to AIIMS or Safdarjang ... of overdosing. //But medical experts say drug overdosed patients should ... get treated, the better are the chances of their survival. ...
... and the 2004 tsunami, was dealt another blow when ... cultural city, a prime tourist destination. // ... and vibrant arts and crafts scene is second only ... ,"We're suffering another setback," said Wulandari, a hotel receptionist ...
... always painstaking and reaps benefits only when done with full dedication. ... Schlegel in Georgetown. This has brought to the world the first ... was when on June 8, the Food and Drug Administration approved ... strains of HPV. ,In the doctor’s own words, "It's ...
Cached Medicine News:Health News:The myth about government hospitals 2Health News:Indonesian Tourism on Downward Trend After Java Quake 2
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: